Literature DB >> 13502695

Immunity to methylcholanthrene-induced sarcomas.

R T PREHN, J M MAIN.   

Abstract

Entities:  

Keywords:  METHYLCHOLANTHRENE; NEOPLASMS/immunology

Mesh：

Substances：

Year:  1957        PMID： 13502695

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  304 in total

1.  Some aspects of the problem of immunity against transplanted and spontaneous tumors.

Authors:  H M HIRSCH
Journal:  Bacteriol Rev       Date:  1962-09

2.  Acquired tolerance, autoantibodies and cancer.

Authors:  B CINADER
Journal:  Can Med Assoc J       Date:  1962-06-23       Impact factor: 8.262

3.  Tumor isoimmunity.

Authors:  H M HIRSCH
Journal:  Experientia       Date:  1958-08-15

4.  IMMUNOLOGY and cancer research.

Authors: 
Journal:  Br Med J       Date:  1958-04-12

Review 5.  Immune recognition of self in immunity against cancer.

Authors:  Alan N Houghton; José A Guevara-Patiño
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 6.  Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.

Authors:  P Höglund; H G Ljunggren; K Kärre; G Jay
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

Review 7.  Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different.

Authors:  Chung-Han Lee; Roman Yelensky; Karin Jooss; Timothy A Chan
Journal:  Trends Immunol       Date:  2018-05-08       Impact factor: 16.687

8.  Mechanisms of Listeria monocytogenes-mediated modulation of tumor growth.

Authors:  A M Fulton; W Croft; M M Dustoor; A A Blazkovec
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

9.  Developing effective tumor vaccines: basis, challenges and perspectives.

Authors:  Qingwen Xu; Weifeng Chen
Journal:  Front Med China       Date:  2007-02-01

Review 10.  Peptide-based vaccines for cancer therapy.

Authors:  Giorgio Parmiani; Vincenzo Russo; Cristina Maccalli; Danilo Parolini; Nathalie Rizzo; Michele Maio
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.